YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

GSK pens $20M deal with 23andMe

Posted online

Pharmaceutical company GSK reached a $20 million deal with 23andMe Holding Co.

The agreement gives GSK access to DNA data from the approximately 80% of 23andMe gene-testing customers who agreed to share their information for research.

It expands upon an existing five-year deal under which GSK can access anonymized DNA data.

Read more from Bloomberg.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences